In vitro and in vivo evaluation of pectin beads for the colon delivery of β-lactamases

Journal of Drug Targeting

Volumn 13, Issue 5, 2005, Pages 277-284

  Bourgeois, Sandrine ^a   Laham, Antoun ^a,b   Besnard, Madeleine ^a   Andremont, Antoine ^a,c   Fattal, Elias ^a  

^a UNIV PARIS SUD   (France)

^b Laboratory of Pharmaceutical Technology   (Syrian Arab Republic)

^c BICHAT HOSPITAL   (France)

Author keywords

lactamase; lactams; Antibiotic resistances; Colon delivery; Pectin beads

Indexed keywords

AMPICILLIN; BETA LACTAMASE; CALCIUM CHLORIDE; PECTIN; POLYETHYLENEIMINE;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; COLON FLORA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG HYDROLYSIS; DRUG STABILITY; ENCAPSULATION; ENZYME ACTIVITY; ENZYME RELEASE; FECES ANALYSIS; GELATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; COLON; CROSS-LINKING REAGENTS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FECES; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; PECTINS;

EID: 24644492781     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860500206583     Document Type: Article

References (38)

1. Adkin DA, Davis SS, Sparrow RA, Wilding IR. 1993. Colonic transit of different sized tablets in healthy subjects. J Control Rel 23:147-156.
2. Andremont A. 2000. Consequences of antibiotic therapy to the intestinal ecosystem. Ann Fr Anesth Reanim 19:395-402.
3. Arvidsson A, Gunnar A, Angelin B, Borga O, Nord CE. 1982. Ceftriaxone: Renal and biliary excretion and effect on colon microflora. J Antimicrob Chemother 10:207-215.
4. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. 1978. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 298:531-534.
5. Batt RM. 1996. Enteric bacteria: Friend or Foe ? J Small Anim Pract 37:261-267.
6. Batycky RP, Hanes J, Langer R, Edwards DA. 1997. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci 86:1464-1477.
7. Bourgeois S, Fattal E, Andremont A, Couvreur P. 2003. PCT/FR03/02474 Forme galénique pour la délivrance colique de principes actifs.
8. Chachaty E, Depitre C, Mario N, Bourneix C, Saulnier P, Corthier G, Andremont A. 1992. Presence of Clostridium difficile and antibiotic and b-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo. Antimicrob Agents Chemother 36:2009-2013.
9. Chachaty E, Bourneix C, Renard S, Bonnay M, Andremont A. 1993. Shedding of Clostridium difficile, fecal b-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime. Antimicrob Agents Chemother 37:1432-1435.
10. Corpet DE. 1987. Antibiotic residues and drug resistance in human intestinal flora. Antimicrob Agents Chemother 31:587-593.
11. Edlund C, Stark C, Nord CE. 1994. The relationship between an increase in b-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. J Antimicrob Chemother 34:127-138.
12. El-Gibaly I. 2002. Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. Int J Pharm 232:199-211.
13. Gorbach SL. 1971. Intestinal microflora. Gastroenterology 60:1110-1129.
14. Harmoinen J, Vaali K, Koski P, Syrjanen K, Laitinen O, Lindevall K, Westermarck E. 2003. Enzymic degradation of a beta-lactam antibiotic, ampicillin, in the gut: A novel treatment modality. J Antimicrob Chemother 51:361-365.
15. Harmoinen J, Mentula S, Heikkila M, van der Rest M, Rajala-Schultz PJ, Donskey CJ, Frias R, Koski P, Wickstrand N, et al. 2004. Orally administered targeted recombinant Beta-lactamase prevents ampicillin-induced selective pressure on the gut microbiota: A novel approach to reducing antimicrobial resistance. Antimicrob Agents Chemother 48:75-79.
16. Hill MJ, Drasar BS. 1975. The normal colonic bacterial flora. Gut 16:318-323.
17. Hovgaard L, Brondsted H. 1996. Current applications of polysaccharides in colon targeting. Crit Rev Ther Drug Carrier Syst 13:185-223.
18. Kim TH, Park YH, Kim KJ, Cho CS. 2003. Release of albumin from chitosan-coated pectin beads in vitro. Int J Pharm 250:371-383.
19. Leonard F, Andremont A, Leclerq B, Labia R, Tancrede C. 1989. Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization. J Infect Dis 160:274-280.
20. Liu P, Krishnan TR. 1999. Alginate-pectin-poly-L-lysine particulate as a potential controlled release formulation. J Pharm Pharmacol 51:141-149.
21. Morris ER, Powell DA, Gidley MJ, Rees DA. 1982. Conformations and interactions of pectins. I. Polymorphism between gel and solid states of calcium polygalacturonate. J Mol Biol 155:507-516.
22. Musabayane CT, Munjeri O, Bwititi P, Osim EE. 2000. Orally administered, insulin-loaded amidated pectin hydrogel beads sustain plasma concentrations of insulin in streptozotocin-diabetic rats. J Endocrinol 164:1-6.
23. Nord CE, Edlund C. 1990. Impact of antimicrobial agents on human intestinal microflora. J Chemother 2:218-237.
24. Nord CE, Edlund C. 1991. Ecological effects of antimicrobial agents on the human intestinal microflora. Microb Ecol Health Dis 4:193-207.
25. Pires de Abreu LR, Ortiz RM, de Castro SC, Pedrazzoli, J, Jr., Pires de Abreu LR, Ortiz RM, de Castro J. Jr. 2003. HPLC determination of amoxicillin comparative bioavailability in healthy volunteers after a single dose administration. J Pharm Pharm Sci 6:223-230.
26. Plaschina IG, Braudo EE, Tolstoguzov VB. 1978. Circulardichroism studies of pectin solutions. Carbohydr Res 60:1-8.
27. Rubinstein A, Radai R. 1995. In vitro and in vivo analysis of colon specificity of calcium pectinate formulations. Eur J Pharm Sci 41:291-295.
28. Semde R, Amighi K, Devleeschouwer MJ, Moes AJ. 2000. Effect of pectinolytic enzymes on the theophylline release from pellets coated with water insoluble polymers containing pectin HM or calcium pectinate. Int J Pharm 197:169-179.
29. Sinha VR, Kumria R. 2003. Microbially triggered drug delivery to the colon. Eur J Pharm Sci 18:3-18.
30. Sriamornsak P. 1998. Investigation on pectin as a carrier for oral delivery of proteins using calcium pectinate gel beads. Int J Pharm 169:213-220.
31. Sriamornsak P. 1999. Effect of calcium concentration, hardening agent and drying condition on release characteristics of oral proteins from calcium pectinate gel beads. Eur J Pharm Sci 8:221-227.
32. Stark C, Edlund C, Hedberg M, Nord CE. 1995. Induction of beta-lactamase production in the anaerobic microflora by cefoxitin. Clin Infect Dis 20:S350-S351.
33. Stiefel U, Pultz NJ, Harmoinen J, Koski P, Lindevall K, Helfand MS, Donskey CJ. 2003. Oral administration of beta-lactamase preserves colonization resistance of piperacillin-treated mice. J Infect Dis 188:1605-1609.
34. Tancrède C, Andremont A, Labia R, Léonard F. 1988. WO8807865 Composition pharmaceutique administrable par voie orale, destinée à réduire les effets des b-lactamines sur la flore intestinale.
35. Thakur BR, Singh RK, Handa AK. 1997. Chemistry and uses of pectin/A review. Crit Rev Food Sci Nutr 37:47-73.
36. Van der Waaij D. 1992. History of recognition and measurement of colonization resistance of digestive tract as an introduction to selective gastrointestinal decontamination. Epidemiol Infect 109:315-326.
37. Van der Waaij D, Nord CE. 2000. Development and persistence of multi-resistance to antibiotics in bacteria; an analysis and a new approach to this urgent problem. Int J Antimicrob Agents 16:191-197.
38. Zhong H-J, Williams MAK, Keenan RD, Goodall DM, Rolin C. 1997. Separation and quantification of pectins using capillary electrophoresis: A preliminary study. Carbohyd Polym 32:27-32.